Showing results (241-250 of 257) with videos related to
Sort By:
Pageof 26
Molecular Pathology : MP|October 2, 2002
Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancerA P M Jongsma, J M J Piek, R P Zweemer, et al.International Journal of Cancer|May 8, 2000
Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptidesS von Mensdorff-Pouilly, E Petrakou, P Kenemans, et al.Cancer Research|September 18, 2001
Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health studyD Tang, D H Phillips, M Stampfer, et al.Cancer Research|November 15, 1996
Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein doseA C van Hof, C F Molthoff, Q Davies, et al.The American Journal of Surgical Pathology|June 23, 2001
Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasiasJ P Baak, A Ørbo, P J van Diest, et al.The New England Journal of Medicine|May 2, 1996
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular diseaseC H Hennekens, J E Buring, J E Manson, et al.Carcinogenesis|April 28, 2000
Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cellsD W Kim, M A Sovak, G Zanieski, et al.Oncogene|July 29, 2014
TRIM24 links glucose metabolism with transformation of human mammary epithelial cellsT N Pathiraja, K N Thakkar, S Jiang, et al.Cancer Immunology, Immunotherapy : CII|October 2, 1998
Biodistribution of 111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01H M Prinssen, C F Molthoff, R H Verheijen, et al.European Journal of Neurology|January 16, 2007
Progression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairmentM Köllensperger, M Stampfer-Kountchev, K Seppi, et al.Pageof 26